Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15096208rdf:typepubmed:Citationlld:pubmed
pubmed-article:15096208lifeskim:mentionsumls-concept:C0040669lld:lifeskim
pubmed-article:15096208lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15096208lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:15096208lifeskim:mentionsumls-concept:C0017837lld:lifeskim
pubmed-article:15096208lifeskim:mentionsumls-concept:C0022173lld:lifeskim
pubmed-article:15096208lifeskim:mentionsumls-concept:C2826170lld:lifeskim
pubmed-article:15096208lifeskim:mentionsumls-concept:C0181586lld:lifeskim
pubmed-article:15096208pubmed:issue9lld:pubmed
pubmed-article:15096208pubmed:dateCreated2004-4-20lld:pubmed
pubmed-article:15096208pubmed:abstractText4-Hydroxy-2-trans-nonenal (4-HNE), one of the major end products of lipid peroxidation, has been shown to induce apoptosis in a variety of cell lines. It appears to modulate signaling processes in more than one way because it has been suggested to have a role in signaling for differentiation and proliferation. We show for the first time that incorporation of 4-HNE-metabolizing glutathione S-transferase (GST) isozyme, hGSTA4-4, into adherent cell lines HLE B-3 and CCL-75, by either cDNA transfection or microinjection of active enzyme, leads to their transformation. The dramatic phenotypic changes due to the incorporation of hGSTA4-4 include rounding of cells and anchorage-independent rapid proliferation of immortalized, rounded, and smaller cells. Incorporation of the inactive mutant of hGSTA4-4 (Y212F) in cells by either microinjection or transfection does not cause transformation, suggesting that the activity of hGSTA4-4 toward 4-HNE is required for transformation. This is further confirmed by the fact that mouse and Drosophila GST isozymes (mGSTA4-4 and DmGSTD1-1), which have high activity toward 4-HNE and subsequent depletion of 4-HNE, cause transformation whereas human GST isozymes hGSTP1-1 and hGSTA1-1, with minimal activity toward 4-HNE, do not cause transformation. In cells overexpressing active hGSTA4-4, expression of transforming growth factor beta1, cyclin-dependent kinase 2, protein kinase C betaII and extracellular signal regulated kinase is upregulated, whereas expression of p53 is downregulated. These studies suggest that alterations in 4-HNE homeostasis can profoundly affect cell-cycle signaling events.lld:pubmed
pubmed-article:15096208pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:languageenglld:pubmed
pubmed-article:15096208pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:citationSubsetIMlld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15096208pubmed:statusMEDLINElld:pubmed
pubmed-article:15096208pubmed:monthMaylld:pubmed
pubmed-article:15096208pubmed:issn0014-2956lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:BrownDavidDlld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:AwasthiSanjay...lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:AwasthiYogesh...lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:SinghSharda...lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:ZimniakPiotrPlld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:YangYusongYlld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:SharmaRajendr...lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:SainiManjit...lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:SinghShivendr...lld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:SharmaAbhaAlld:pubmed
pubmed-article:15096208pubmed:authorpubmed-author:PatrickBradBlld:pubmed
pubmed-article:15096208pubmed:issnTypePrintlld:pubmed
pubmed-article:15096208pubmed:volume271lld:pubmed
pubmed-article:15096208pubmed:ownerNLMlld:pubmed
pubmed-article:15096208pubmed:authorsCompleteYlld:pubmed
pubmed-article:15096208pubmed:pagination1690-701lld:pubmed
pubmed-article:15096208pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:meshHeadingpubmed-meshheading:15096208...lld:pubmed
pubmed-article:15096208pubmed:year2004lld:pubmed
pubmed-article:15096208pubmed:articleTitleTransfection with 4-hydroxynonenal-metabolizing glutathione S-transferase isozymes leads to phenotypic transformation and immortalization of adherent cells.lld:pubmed
pubmed-article:15096208pubmed:affiliationDepartment of Human Biological Chemistry and Genetics, University of Texas Medical Branch, Galveston, TX 77555-0647, USA.lld:pubmed
pubmed-article:15096208pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15096208pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:41503entrezgene:pubmedpubmed-article:15096208lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15096208lld:pubmed